P29317 (EPHA2_HUMAN) Homo sapiens (Human)
Ephrin type-A receptor 2 UniProtKBInterProSTRINGInteractive Modelling
976 aa; Sequence (Fasta) ; (Isoform 2)
It is possible new templates exist for this target since these models were created.
Available Structures
99 Experimental Structures
| Description | PDB ID | Oligo-state | Range | Ligands | ||
|---|---|---|---|---|---|---|
| Crystal structure of the complete EphA2 ectodomain in complex with ephrin A5 receptor binding domain |
Heteromer P52803; | |||||
| Assess | ||||||
| Crystal Structure of EphA2 ectodomain in complex with ephrin-A5 |
Heteromer P52803; | 1×NAG; 1×NAG; | ||||
| Assess | ||||||
| Crystal structure of the human ephrin A2 LBD and CRD domains in complex with ephrin A1 |
Heteromer P20827; | 2×NAG; 2×UNX; | ||||
| Assess | ||||||
| Crystal structure of Kaposi Sarcoma associated herpesvirus (KSHV ) gHgL in complex with the ligand … |
Heteromer Q76RG7; Q98142; | 1×NAG; 2×NAG; 6×NAG; | ||||
| Assess | ||||||
| Structural And Functional Characterization of an Agonistic Anti-Human EphA2 Monoclonal Antibody |
Heteromer | |||||
| Assess | ||||||
| Bicycle Toxin Conjugate bound to EphA2 |
Heteromer | 1×GOL; 1×29N; | ||||
| Assess | ||||||
| Crystal structure of the human ephrin A2- ephrin A1 complex |
Heteromer P20827; | 1×NAG; | ||||
| Assess | ||||||
| Ligand Recognition by A-Class Eph Receptors: Crystal Structures of the EphA2 Ligand-Binding Domain … |
Heteromer P20827; | |||||
| Assess | ||||||
| Human herpesvirus-8 gH/gL in complex with EphA2 |
Heteromer F5HDB7; Q98142; | 2×NAG; 4×CL; 10×NA; 2×NAG; | ||||
| Assess | ||||||
| Crystal structure of Epstein-Barr virus (EBV) gHgL and in complex with the ligand binding domian (L… |
Heteromer P03212; P03231; | 4×NAG; | ||||
| Assess | ||||||
| Structure of the EphA2 CRD bound to FabS1CE_C1, trigonal form |
Heteromer | 19×EDO; 7×PEG; 17×CL; 1×NA; | ||||
| Assess | ||||||
| Structure of the EphA2 CRD bound to FabS1CE_C1, monoclinic form |
Heteromer | 2×CL; | ||||
| Assess | ||||||
| Structure of the CK variant of Fab F1 (FabC-F1) in complex with the C-terminal FN3 domain of EphA2 |
Heteromer | |||||
| Assess | ||||||
| Co-crystal structure of the sam domains of EPHA1 AND EPHA2 |
Heteromer P21709; | 1×CL; | ||||
| Assess | ||||||
| EphA2:SHIP2 SAM:SAM complex |
Heteromer O15357; | |||||
| Assess | ||||||
| Crystal structure of EphA2 with peptide 135E2 | homo-4-mer | |||||
| Assess | ||||||
| Crystal structure of the human ephrin A2 ectodomain | homo-2-mer | 2×NA; 6×CL; 2×NAG; | ||||
| Assess | ||||||
| Structure of the autoinhibited Epha2 JMS-KD | homo-2-mer | |||||
| Assess | ||||||
| Structure of Ephrin type-A receptor 2 | homo-2-mer | |||||
| Assess | ||||||
| Crystal structure of the ligand binding domain of human Ephrin A2 (Epha2) receptor protein kinase | homo-2-mer | |||||
| Assess | ||||||
| EphA2 dimeric structure in the lipidic bicelle at pH 5.0 | homo-2-mer | |||||
| Assess | ||||||
| Crystal structure of the complete EphA2 ectodomain | monomer | 1×CL; 1×NAG; | ||||
| Assess | ||||||
| Crystal structure of the EphA2 intracellular KD-SAM domains | monomer | 2×GOL; 1×ACP; 1×MG; | ||||
| Assess | ||||||
| Crystal structure of the EphA2 S901E mutant intracellular KD-SAM domains | monomer | 1×ACP; 1×MG; 2×GOL; | ||||
| Assess | ||||||
| Crystal structure of the EphA2 S897E/S901E mutant intracellular KD-SAM domains | monomer | 1×CS; | ||||
| Assess | ||||||
| Crystal Structure of Ephrin A2 (EphA2) Receptor Protein Kinase with an isomer of NVP-BHG712 | monomer | 1×DWT; 6×EDO; | ||||
| Assess | ||||||
| Crystal Structure of Ephrin A2 (EphA2) Receptor Protein Kinase with Compound 2b | monomer | 1×8ZZ; 1×EDO; | ||||
| Assess | ||||||
| Crystal Structure of Ephrin A2 (EphA2) Receptor Protein Kinase with the NVP-BHG712 derivative ATDL09 | monomer | 1×HO5; | ||||
| Assess | ||||||
| Crystal Structure of Ephrin A2 (EphA2) Receptor Protein Kinase with the NVP-BHG712 derivative ATDL11 | monomer | 1×HOK; | ||||
| Assess | ||||||
| Crystal Structure of Ephrin A2 (EphA2) Receptor Protein Kinase with the NVP-BHG712 derivative AT050 | monomer | 1×G0H; 1×EDO; | ||||
| Assess | ||||||
| Crystal Structure of Ephrin A2 (EphA2) Receptor Protein Kinase with the NVP-BHG712 derivative ATDL13 | monomer | 1×HOT; | ||||
| Assess | ||||||
| Crystal Structure of Ephrin A2 (EphA2) Receptor Protein Kinase with dasatinib | monomer | 1×1N1; 3×EDO; | ||||
| Assess | ||||||
| Crystal Structure of Ephrin A2 (EphA2) Receptor Protein Kinase with the NVP-BHG712 derivative AT061 | monomer | 1×G0K; | ||||
| Assess | ||||||
| Crystal Structure of Ephrin A2 (EphA2) Receptor Protein Kinase with the NVP-BHG712 derivative ATNK0… | monomer | 1×FZW; | ||||
| Assess | ||||||
| Crystal Structure of Ephrin A2 (EphA2) Receptor Protein Kinase with Compound 2i | monomer | 1×91K; 1×EDO; | ||||
| Assess | ||||||
| Crystal Structure of Ephrin A2 (EphA2) Receptor Protein Kinase with the NVP-BHG712 derivative AT058 | monomer | 1×G0N; | ||||
| Assess | ||||||
| Crystal Structure of Ephrin A2 (EphA2) Receptor Protein Kinase with the NVP-BHG712 derivative ATHA01 | monomer | 1×HO8; | ||||
| Assess | ||||||
| Crystal Structure of Ephrin A2 (EphA2) Receptor Protein Kinase with the NVP-BHG712 derivative ATDL14 | monomer | 1×HMW; | ||||
| Assess | ||||||
| Crystal Structure of Ephrin A2 (EphA2) Receptor Protein Kinase with Compound 2h | monomer | 1×90T; 1×EDO; | ||||
| Assess | ||||||
| Crystal Structure of Ephrin A2 (EphA2) Receptor Protein Kinase with Compound 2c | monomer | 1×90E; 1×EDO; | ||||
| Assess | ||||||
| Crystal Structure of Ephrin A2 (EphA2) Receptor Protein Kinase with Compound 7 | monomer | 1×QUU; | ||||
| Assess | ||||||
| Crystal Structure of Ephrin A2 (EphA2) Receptor Protein Kinase with Compound 3e | monomer | 1×8ZQ; | ||||
| Assess | ||||||
| Crystal Structure of Ephrin A2 (EphA2) Receptor Protein Kinase with PD173955 | monomer | 1×P17; | ||||
| Assess | ||||||
| Crystal Structure of Ephrin A2 (EphA2) Receptor Protein Kinase | monomer | 1×EDO; | ||||
| Assess | ||||||
| Crystal Structure of Ephrin A2 (EphA2) Receptor Protein Kinase with Compound 8 | monomer | 1×R0T; | ||||
| Assess | ||||||
| Crystal Structure of Ephrin A2 (EphA2) Receptor Protein Kinase with bosutinib (SKI-606) | monomer | 1×DB8; 4×EDO; | ||||
| Assess | ||||||
| Crystal Structure of Ephrin A2 (EphA2) Receptor Protein Kinase with Compound 1k | monomer | 1×90N; | ||||
| Assess | ||||||
| Crystal Structure of Ephrin A2 (EphA2) Receptor Protein Kinase with Compound 1j | monomer | 1×91E; | ||||
| Assess | ||||||
| Crystal Structure of Ephrin A2 (EphA2) Receptor Protein Kinase with Compound 9 | monomer | 1×R0O; | ||||
| Assess | ||||||
| Crystal Structure of Ephrin A2 (EphA2) Receptor Protein Kinase with Compound 4b | monomer | 1×8ZW; | ||||
| Assess | ||||||
| Crystal Structure of Ephrin A2 (EphA2) Receptor Protein Kinase with danusertib (PHA739358) | monomer | 1×627; 1×EDO; | ||||
| Assess | ||||||
| Crystal Structure of Ephrin A2 (EphA2) Receptor Protein Kinase with Compound 1g | monomer | 1×8ZH; | ||||
| Assess | ||||||
| Crystal Structure of Ephrin A2 (EphA2) Receptor Protein Kinase with Compound 2a | monomer | 1×8ZZ; | ||||
| Assess | ||||||
| Crystal Structure of Ephrin A2 (EphA2) Receptor Protein Kinase with Compound 3b | monomer | 1×8ZN; | ||||
| Assess | ||||||
| Crystal Structure of Ephrin A2 (EphA2) Receptor Protein Kinase with Compound 3d | monomer | 1×8ZK; | ||||
| Assess | ||||||
| Crystal Structure of Ephrin A2 (EphA2) Receptor Protein Kinase with Compound 14 | monomer | 1×QU6; | ||||
| Assess | ||||||
| Crystal Structure of Ephrin A2 (EphA2) Receptor Protein Kinase with the NVP-BHG712 derivative ATDL18 | monomer | 1×HNZ; | ||||
| Assess | ||||||
| Crystal Structure of Ephrin A2 (EphA2) Receptor Protein Kinase with the NVP-BHG712 derivative AT055 | monomer | 1×G0Q; | ||||
| Assess | ||||||
| Crystal Structure of Ephrin A2 (EphA2) Receptor Protein Kinase with Compound 2d | monomer | 1×90W; | ||||
| Assess | ||||||
| Crystal Structure of Ephrin A2 (EphA2) Receptor Protein Kinase with the NVP-BHG712 derivative AT069 | monomer | 1×G0E; | ||||
| Assess | ||||||
| Crystal Structure of Ephrin A2 (EphA2) Receptor Protein Kinase with Compound 1m | monomer | 1×90K; | ||||
| Assess | ||||||
| Crystal Structure of Ephrin A2 (EphA2) Receptor Protein Kinase with Compound 3a | monomer | 1×90B; | ||||
| Assess | ||||||
| Crystal Structure of Ephrin A2 (EphA2) Receptor Protein Kinase with the NVP-BHG712 derivative ATMM0… | monomer | 1×G02; | ||||
| Assess | ||||||
| Crystal Structure of Ephrin A2 (EphA2) Receptor Protein Kinase with AGS | monomer | 1×AGS; | ||||
| Assess | ||||||
| Crystal Structure of Ephrin A2 (EphA2) Receptor Protein Kinase with Compound 4a | monomer | 1×8ZT; 2×EDO; | ||||
| Assess | ||||||
| Crystal Structure of Ephrin A2 (EphA2) Receptor Protein Kinase with Compound 20 | monomer | 1×QTX; | ||||
| Assess | ||||||
| The Crystal Structure of EphA2 from Biortus. | monomer | 1×4Z5; 1×GOL; 5×EDO; | ||||
| Assess | ||||||
| Crystal Structure of Ephrin A2 (EphA2) Receptor Protein Kinase with Compound 2e | monomer | 1×912; | ||||
| Assess | ||||||
| Crystal structure of human Ephrin type-A receptor 2 (EPHA2) Kinase domain in complex with JG165 | monomer | 1×WT3; 13×EDO; | ||||
| Assess | ||||||
| Crystal Structure of Ephrin A2 (EphA2) Receptor Protein Kinase with Compound 12 | monomer | 1×R3L; | ||||
| Assess | ||||||
| Crystal Structure of Ephrin A2 (EphA2) Receptor Protein Kinase with ANP | monomer | 1×ANP; 2×EDO; | ||||
| Assess | ||||||
| Crystal Structure of Ephrin A2 (EphA2) Receptor Protein Kinase with Compound 2g | monomer | 1×91H; 1×EDO; | ||||
| Assess | ||||||
| Crystal Structure of Ephrin A2 (EphA2) Receptor Protein Kinase with compound 66 | monomer | 1×L66; 3×EDO; | ||||
| Assess | ||||||
| Crystal structure of human Ephrin type-A receptor 2 (EPHA2) Kinase domain in complex with MRAL5 | monomer | 13×EDO; 1×QRD; | ||||
| Assess | ||||||
| Crystal Structure of Ephrin A2 (EphA2) Receptor Protein Kinase with Compound 2f | monomer | 1×90Z; | ||||
| Assess | ||||||
| Crystal Structure of Ephrin A2 (EphA2) Receptor Protein Kinase with NVP-BHG712 | monomer | 1×DXH; | ||||
| Assess | ||||||
| Crystal Structure of Ephrin A2 (EphA2) Receptor Protein Kinase with a pyrazolo[3,4-d]pyrimidine fra… | monomer | 1×DXK; 11×EDO; | ||||
| Assess | ||||||
| Crystal Structure of Ephrin A2 (EphA2) Receptor Protein Kinase with Compound 1l | monomer | 1×92Q; 1×EDO; | ||||
| Assess | ||||||
| Crystal Structure of Ephrin A2 (EphA2) Receptor Protein Kinase with alisertib (MLN8237) | monomer | 1×A5B; 6×EDO; | ||||
| Assess | ||||||
| Crystal Structure of Ephrin A2 (EphA2) Receptor Protein Kinase with Compound 11 | monomer | 1×R0X; | ||||
| Assess | ||||||
| Crystal Structure of Ephrin A2 (EphA2) Receptor Protein Kinase with Compound 19 | monomer | 1×QUF; | ||||
| Assess | ||||||
| Crystal Structure of Ephrin A2 (EphA2) Receptor Protein Kinase with MLN8054 | monomer | 1×ZZL; 1×EDO; | ||||
| Assess | ||||||
| Crystal structure of human Ephrin type-A receptor 2 (EPHA2) Kinase domain in complex with MR21 | monomer | 7×EDO; 1×QRR; | ||||
| Assess | ||||||
| Crystal structure of human Ephrin type-A receptor 2 (EPHA2) Kinase domain in complex with LDN-211904 | monomer | 8×EDO; 1×QJI; | ||||
| Assess | ||||||
| Crystal Structure of Ephrin A2 (ephA2) Receptor Protein Kinase | monomer | 1×ANP; | ||||
| Assess | ||||||
| Structure of Ephrin type-A receptor 2 | monomer | |||||
| Assess | ||||||
| Structure of Ephrin type-A receptor 2 | monomer | |||||
| Assess | ||||||
| Crystal Structure of Ephrin A2 (EphA2) Receptor Protein Kinase with golvatinib (E7050) | monomer | 1×GV0; 3×EDO; | ||||
| Assess | ||||||
| Crystal Structure of Ephrin A2 (EphA2) Receptor Protein Kinase with foretinib (XL880) | monomer | 1×88Z; 1×EDO; | ||||
| Assess | ||||||
| Ligand recognition by A-class EPH receptors: crystal structures of the EPHA2 ligand-binding domain … | monomer | |||||
| Assess | ||||||
| EphA2 LBD in complex with bA-WLA-Yam peptide | monomer | 2×GOL; 1×ACA; 1×EDO; | ||||
| Assess | ||||||
| EphA2 LBD in complex with bA-WLA-YRPKbio peptide | monomer | |||||
| Assess | ||||||
| EphA2 LBD in complex with YSA-GSGSK-bio peptide | monomer | 3×GOL; 1×BTN; | ||||
| Assess | ||||||
| EphA2 LBD in complex with bA-WLA-YSKbio peptide | monomer | 1×BTN; | ||||
| Assess | ||||||
| EphA2 LBD in complex with bA-WLA-YRPK bio peptide | monomer | 1×PEG; | ||||
| Assess | ||||||
| Solution structure of the C-terminal SAM-domain of EphaA2: Ephrin type-A receptor 2 precursor (EC 2… | monomer | |||||
| Assess | ||||||
| NMR structure of EphA2-Sam stapled peptides (S13ST) | monomer | |||||
| Assess | ||||||
| NMR structure of an EphA2-Sam fragment | monomer | |||||
| Assess | ||||||
| NMR structure of EphA2-Sam stapled peptides (S13STshort) | monomer | |||||
| Assess | ||||||
4 SWISS-MODEL models
| Template | Oligo-state | QMEANDisCo | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|
| 7kjb.1.A | monomer | 0.76 | 1×CS; | 99.48 | ||
| Assess | ||||||
| 7kja.1.A | monomer | 0.76 | 1×ACP; | 100.00 | ||
| Assess | ||||||
| 7kja.2.A | monomer | 0.75 | 100.00 | |||
| Assess | ||||||
| 3fl7.1.A | monomer | 0.74 | 100.00 | |||
| Assess | ||||||
3 SWISS-MODEL models built on isoform sequence
| Template | Isoform | Oligo-state | QMEANDisCo | Range | Ligands | Trg-Tpl Seq id (%) |
|---|---|---|---|---|---|---|
| Isoform 2 | 3fl7.1.A | monomer | 0.78 | 99.34 | ||
| Assess | ||||||
| Isoform 2 | 4m4p.1.A | monomer | 0.68 | 47.57 | ||
| Assess | ||||||
| Isoform 2 | 4m4r.2.A | monomer | 0.67 | 47.57 | ||
| Assess | ||||||